Abstract A new member of the piericidin family, JBIR-02, was isolated from mycelium of Streptomyces sp. ML55 together with two known piericidin derivatives, piericidin A 1 and IT-143-B. The structure was determined on the basis of spectroscopic data. JBIR-02 inhibited nuclear export of b-arrestin in HeLa cells at the concentration of 20 mM.
1.0% molasses, 0.5% casein, 0.1% polypepton, 0.4% CaCO 3 (pH 7.2 before sterilization). The mycelium from the cultured broth (2 liters) was extracted with acetone. After concentrated in vacuo, the residue was extracted with EtOAc for two times. The ethyl acetate layer was dried over Na 2 SO 4 , and concentrated in vacuo. The dried residue was applied to normal-phase MPLC (Purif-Pack SI-60, Moritex) and developed with a n-hexane -EtOAc linear gradient system to yield two active fractions (40ϳ50% and 90ϳ100% EtOAc eluents). The second active eluate (90ϳ100% EtOAc) was subjected to preparative reversedphase HPLC (85% MeOH -H 2 O, Senshu Pak PEGASIL ODS 20 i.d.ϫ250 mm) to yield 1 (3.2 mg, Rtϭ21.0 minutes) as an active compound. Piericidin A 1 (2, 10.4 mg) [6] and IT-143-B (3, 13.7 mg) [7] which existed in the first MPLC fractions (40ϳ50% EtOAc eluate) were isolated with reversed-phase MPLC (85% MeOH -H 2 O, Purif-Pack ODS 100, Moritex).
1 was obtained as a brown amorphous solid. The physico-chemical properties of 1 are summarized in Table  1 . Its HR-ESI-MS (m/z 426.2979) data indicated its molecular formula to be C 27 H 39 NO 3 . The UV spectrum of 1 resembled those of piericidins, which suggested the presence of 4-hydroxy-pyridine moiety as a chromophore [3ϳ5]. The 1 H-and 13 C-NMR data of 1 are shown in Table  2 . The structure elucidation was carried out mainly utilizing the major tautomer of 1. The analysis of 1 H-NMR data and 1 H-1 H COSY spectra of 1 revealed two sets of signals in 3 : 1 ratio of intensity, which showed that 1 mainly consisted of pyridone structure vide infra. The 1 H-1 H COSY spectra of 1 revealed the two 2-butenyl, two propenyl and a 1-hydroxy-2-methyl-3-pentenyl moieties as shown by bold line in Fig. 2 . The connectivity of these partial structures was elucidated as follows. C chemical shift value of C-3Ј, the methyl residue was deduced to be placed at C-2Ј. A long-range coupling between an aromatic proton 4Ј-H (d H 6.40) and C-2Ј was observed. In addition, the methoxyl proton 5Ј-O-Me (d H 3.85) was found longrange coupled to C-5Ј (d C 159.6), of which 13 C-chemical shift is almost identical to that of Mer-A2026A (d C 160.4) [8] . Therefore, the pyridone moiety of 1 was established as shown in Fig. 2A . The geometry of olefins was deduced to be 2E, 5E, 7E, 11E, 13E-form, respectively, based on the ROE correlations between 1-H and 3-Me, 2-H and 4-H, 4-H and 6-H, 6-H and 8-H, 7-Me and 9-H, and 10-H and 12-H, along with NOE between 12-H and 14-H. In the same manner, a 4-hydroxypyridine tautomer was also determined as shown in Fig. 2B . Thus, the structure of 1 was concluded 3 : 1 ratio of tautomeric mixture as shown in Fig. 1 .
We found that 1 and 2 inhibited the export of b-arrestin 2-EYFP (Enhanced Yellow Fluorescent Protein) fusion protein from nuclear in HeLa cells at a concentration of 20 and 40 m M, respectively (Fig. 3) . Surprisingly, 3 did not show nuclear export inhibition at the concentration of 80 mM (Fig. 3) . However, we could not examine inhibitory activity of 3 at a high concentration because 3 induced cell death for HeLa cells at more than 80 mM (data not shown). The compound 3 might inhibit the export of b -arrestin 2 from nuclear if another cell line except HeLa cells is treated with 3 at a high concentration. Leptomycin, another nuclear export inhibitor, can undergo a Michael-type addition by Cysteine-529 on the exportin CRM1 [9, 10] . This covalent modification inhibits binding between chromosomal region maintenance (CRM1) and the nuclear export signal (NES)-containing cargo. Leptomycin B showed nuclear export inhibition of b-arrestin 2-EYFP at the concentration of 5 nM (data not shown). Contrary to leptomycin, the hydroxypyridine form of 1 and 2 could not make covalent bond to CRM1 by Michael-type addition. Also, if Michael addition to the Cys-residue occurs on the 461 pyridone-ring of 1, the hypothetical Cys adduct might be energetically unfavorable product because the aromaticity of pyridone-ring would lose. Accordingly, the inhibitory activities of 1 and 2 are very weak compared with leptomycin B. However, 1 and 2 possibly might act on the pocket which leptomycin covalently binds to CRM1, since they are structurally resembled leptomycin consisting of an aromatic 6-membered ring moiety with branched side chain. Studies on detailed biological activities of 1 and 2 are now underway.
